Effects of reboxetine on sleep and nocturnal cardiac autonomic activity in patients with dysthymia

Journal of Psychopharmacology

Volumn 18, Issue 3, 2004, Pages 417-422

  Ferini Strambi, Luigi ^a   Manconi, Mauro ^a   Castronovo, Vincenza ^a   Riva, Laura ^a   Bianchi, Anna ^b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b POLITECNICO DI MILANO   (Italy)

Author keywords

Cardiac autonomic activity; Dysthymia; Insomnia; Polysomnography; Reboxetine; Sleep

Indexed keywords

ANTIDEPRESSANT AGENT; REBOXETINE;

ADULT; AROUSAL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DYSTHYMIA; FEMALE; HEART AUTOMATICITY; HEART RATE VARIABILITY; HUMAN; LONG TERM CARE; MALE; PARASOMNIA; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP DEPRIVATION; SIDE EFFECT; SINGLE BLIND PROCEDURE; SLEEP; SPECTROSCOPY; SYMPATHETIC TONE;

ADRENERGIC UPTAKE INHIBITORS; ADULT; ANTIDEPRESSIVE AGENTS; AUTONOMIC NERVOUS SYSTEM; CIRCADIAN RHYTHM; DYSTHYMIC DISORDER; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; SINGLE-BLIND METHOD; SLEEP STAGES; WAKEFULNESS;

EID: 6044246274     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110401800313     Document Type: Article

References (34)

1. Armitage R, Rush A J, Trivedi M, Cain J, Roffwarg H (1994) The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology 10: 123-127
2. Baldwin D S, Carabal E (1999) Reboxetine, a selective noradrenaline reuptake inhibitor for the treatment of depression. Drugs Today 35: 719-724
3. Baldwin D S, Buis C, Carabal E (2000) Tolerability and safety of reboxetine. Rev Contemp Pharmacother 11 321-330
4. Beck A T, Ward C H, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-71
5. Berzewski H, van Moffaert M, Gagiano C A (1997) Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodes. Eur Neuropsychopharmacol 7 (Suppl 1): S37-S47
6. Bianchi A M, Mainardi L, Petrucci E, Signorini M G, Mainardi M, Cerutti S (1993) Time variant power spectrum analysis for the detection of transient episodes in HRV signal. IEEE Trans Biomed Eng 40: 136-144
7. Carvalhal A S, de Abreu P B, Spode A, Correa J, Kapczineski F (2003) An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder. J Clin Psychiatry 64 (4): 421-424
8. Denolle T, Pellizzoni C, Jannuzzo M G, Poggesi I (1999) Hemodynamic effects of reboxetine in healthy male volunteers. Clin Pharmacol Ther 60: 282-287
9. Farina B, Della Marca G, Mennuni G, Mazza S, De Risio S, Di Giannantonio M (2002) The effects of reboxetine on human sleep architecture in depression: preliminary results. J Affect Disord 71: 273-275
10. Ferini-Strambi L, Oldani A, Zucconi M, Smirne S (1996) Cardiac autonomic activity during wakefulness and sleep in REM sleep behavior disorder. Sleep 19: 367-369
11. Ferini-Strambi L, Spera A, Oldani A, Zucconi M, Bianchi A M, Cerutti S, Smirne S (1997) Autonomic function in narcolepsy: power spectrum analysis of heart rate variability. J Neurol 244: 252-255
12. Ferini-Strambi L, Smirne S (1998) Cardiac autonomic function during sleep in several neuropsychiatric disorders. J Neurol 244 (Suppl 1): S29-S36
13. Maeda Y, Hayashi T, Furuta H, Kim Y, Morikawa K, Ishiguro N, Ueno K, Sano J, Yamaguchi N (1990-91) Effects of mianserin on human sleep. Neuropsychobiology 24: 198-204
14. Malliani A, Pagani M, Lombardi F, Cerutti S (1991) Cardiovascular neural regulation explored in the frrequency domain. Circulation 84: 1482-1492
15. Mancia G (1993) Autonomic modulation of the cardiovascular system during sleep. N Engl J Med 328: 347-349
16. Mucci M (1997) Reboxetine: a review of antidepressant tolerability. J Psychopharmacol 11 (Suppl 4): S33-S37
17. Nicholson A N, Pascoe P A (1991) Presynaptic alpha 2-adrenoceptor function and sleep in man: studies with clonidine and idazoxan. Neuropharmacology 30: 367-372
18. Penttila J, Syvalahti E, Hinkka S, Kuusela T, Scheinin H (2001) The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers. Psychopharmacology 154: 343-349
19. Ray W A (1992) Psychotropic drugs and injuries among the elderly: a review. J Clin Psychopharmacol 12: 382-386
20. Rechtschaffen A, Kales A (1968) A manual of standardized terminology techniques and scoring system of sleep stages of human subjects. US Government Printing Office: Washington Public Health Service, Washington, DC
21. Riva M, Brunello N, Rovescalli A C (1989) Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: behavioural and biochemical studies. J Drug Dev 1: 243-253
22. Schatzberg A F (2000) Clinical efficacy of reboxetine in major depression. J Clin Psychiatry 61 (Suppl 10): 31-38
23. Stahl S M, Mendels J, Schwartz G E (2002) Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomised clinical trials. J Clin Psychopharmacol 22: 388-92
24. Szabadi E, Bradshaw C M (2000) Mechanisms of action of reboxetine. Rev Contemp Pharmacother 11: 267-282
25. Szabadi E, Bradshaw C M, Boston P F, Langley R W (1998) The human pharmacology of reboxetine. Hum Psychopharmacol Clin Exp 13: S3-S12
26. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043-1065
27. Thase M E (1999) Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry 60 (Suppl 17): 28-31
28. Ursin R (2002) Serotonin and sleep. Sleep Med Rev 6: 55-69
29. Vogel G (1983) Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs. Progr Neuropsychopharmacol Biol Psychiatry 7: 343-349
30. Vogel G, Buffenstein A, Minter K, Hennessey A (1990) Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev 14: 49-63
31. Vogel G, Cohen J, Mullis D, Kensler T, Kaplita S (1998) Nefazodone and REM sleep: how do antidepressant drugs decrease REM sleep? Sleep 21: 70-77
32. Warrington S J, Padgham C, Lader M (1989) The cardiovascular effects of antidepressants. Psychological Medicine Monograph, Supplement 16. Cambridge University Press, Cambridge
33. Winokur A, Gary K A, Rodner S, Rae-Red C, Fernando A T, Szuba M P (2001) Depression, sleep physiology, and antidepressant drugs. Depress Anxiety 14: 19-28
34. Wong E H, Sonders M S, Amara S G, Tinholt P M, Piercey M F, Hoffmann W P, Hyslop D K, Franklin S, Porsolt R D, Bonsignori A, Carfágna N, McArthur R A (2000) Reboxetine: a pharmacologically potent, selective and specific norepinephrine reuptake inhibitor. Biol Psychiatry 47: 818-829